Jd Health International Stock Net Income
| JDHIF Stock | USD 7.58 0.00 0.00% |
As of the 17th of February 2026, JD Health owns the Market Risk Adjusted Performance of 0.5223, coefficient of variation of (1,397), and Information Ratio of (0.1). JD Health International technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out JD Health International standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if JD Health International is priced more or less accurately, providing market reflects its prevailing price of 7.58 per share. Given that JD Health International has variance of 6.44, we strongly advise you to confirm JD Health's latest market performance to make sure the company can sustain itself sooner or later.
JD Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing JD Health's valuation are provided below:JD Health International does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. JDHIF |
JD Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to JD Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of JD Health.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in JD Health on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding JD Health International or generate 0.0% return on investment in JD Health over 90 days. JD Health is related to or competes with Fresenius, Otsuka Holdings, Bayer AG, Koninklijke Philips, Terumo Corp, Fresenius Medical, and Sartorius Stedim. JD Health International Inc., an investment holding company, operates an online healthcare platform in the Peoples Repub... More
JD Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure JD Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess JD Health International upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 19.2 |
JD Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for JD Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as JD Health's standard deviation. In reality, there are many statistical measures that can use JD Health historical prices to predict the future JD Health's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | 0.5123 |
JD Health February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | 0.5223 | |||
| Mean Deviation | 0.5763 | |||
| Coefficient Of Variation | (1,397) | |||
| Standard Deviation | 2.54 | |||
| Variance | 6.44 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | 0.5123 | |||
| Maximum Drawdown | 19.2 | |||
| Skewness | (6.29) | |||
| Kurtosis | 51.32 |
JD Health International Backtested Returns
JD Health International retains Efficiency (Sharpe Ratio) of -0.075, which attests that the entity had a -0.075 % return per unit of price deviation over the last 3 months. JD Health exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out JD Health's Information Ratio of (0.1), market risk adjusted performance of 0.5223, and Coefficient Of Variation of (1,397) to validate the risk estimate we provide. The company owns a Beta (Systematic Risk) of -0.37, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning JD Health are expected to decrease at a much lower rate. During the bear market, JD Health is likely to outperform the market. At this point, JD Health International has a negative expected return of -0.2%. Please make sure to check out JD Health's treynor ratio, and the relationship between the standard deviation and kurtosis , to decide if JD Health International performance from the past will be repeated sooner or later.
Auto-correlation | 0.00 |
No correlation between past and present
JD Health International has no correlation between past and present. Overlapping area represents the amount of predictability between JD Health time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of JD Health International price movement. The serial correlation of 0.0 indicates that just 0.0% of current JD Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, JD Health International reported net income of (1.07 Billion). This is 414.55% lower than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The net income for all United States stocks is significantly higher than that of the company.
JDHIF Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JD Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of JD Health could also be used in its relative valuation, which is a method of valuing JD Health by comparing valuation metrics of similar companies.JD Health is currently under evaluation in net income category among its peers.
JDHIF Fundamentals
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0099 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 29.92 B | |||
| Shares Outstanding | 3.18 B | |||
| Shares Owned By Insiders | 68.29 % | |||
| Shares Owned By Institutions | 10.16 % | |||
| Price To Book | 4.24 X | |||
| Price To Sales | 1.21 X | |||
| Revenue | 30.68 B | |||
| Gross Profit | 7.2 B | |||
| EBITDA | (895.49 M) | |||
| Net Income | (1.07 B) | |||
| Cash And Equivalents | 45.68 B | |||
| Cash Per Share | 14.37 X | |||
| Total Debt | 194.3 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.89 X | |||
| Book Value Per Share | 13.33 X | |||
| Cash Flow From Operations | 3.43 B | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 2.54 K | |||
| Beta | 0.49 | |||
| Market Capitalization | 30.5 B | |||
| Total Asset | 48 B | |||
| Z Score | 93.6 | |||
| Net Asset | 48 B |
About JD Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze JD Health International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JD Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JD Health International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in JDHIF Pink Sheet
JD Health financial ratios help investors to determine whether JDHIF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in JDHIF with respect to the benefits of owning JD Health security.